CDMO - January 23, 2026
Northern Sweden: Diamyd Medical deepens manufacturing collaboration
Diamyd Medical is taking the next step in a long-term manufacturing collaboration with APL and, in parallel, is initiating a strategic collaboration with NorthX Biologics to further develop and scale the manufacturing of retogatein (rhGAD65) ahead of commercialization.
CDMO - December 1, 2025
NorthX Biologics and Mendus complete GMP manufacturing certification
The GMP manufacturing certification concerns Mendus’ lead cell therapy product, vididencel.
CDMO - September 24, 2025
PolyPeptide Group achieves milestone in Malmö expansion
PolyPeptide Group has announced the successful delivery and installation of pre-built modules at its Malmö, Sweden facility.
Acquisition - July 30, 2025
Ofichem acquires Meribel Pharma Solutions’ Uppsala site
The Uppsala site, formerly part of Recipharm and known as OT Chemistry, is home to 20 employees and specializes in small-scale, early-phase development work.
CDMO - June 9, 2025
ReciBioPharm expand collaboration with University of Oxford
The University of Oxford and ReciBioPharm, Recipharm’s Advanced Biologics division are expanding their collaboration with the development of two blood-stage malaria vaccine candidates for Phase 1/2 clinical trials.
CDMO - May 15, 2025
NorthX Biologics secures growth investment
NorthX Biologics has announced an investment from Signet Healthcare Partners, a US-based healthcare private equity firm with expertise in pharmaceutical services.
